Cargando…
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
Therapeutic agents aimed at inhibiting a single molecular target have not been successful in cancer therapy, but rather they impart resistance. However, multi-target inhibitors have shown promising results in circumventing the development of resistance and inducing apoptosis in cancer cells/tissues....
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863640/ https://www.ncbi.nlm.nih.gov/pubmed/29593389 http://dx.doi.org/10.2147/IJN.S124701 |